 In Kenya, the vaccine produced from sheep or goatpox viruses has been shown to provide immunity in cattle.However, the level of attenuation required for safe use in sheep and goats is not sufficient for cattle.For this reason the sheeppox and goatpox vaccines are restricted to countries where sheeppox or goatpox is already endemic since the live vaccines could provide a source of infection for the susceptible sheep and goat populations.